These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Additive value of low-dose dobutamine to technetium-99m sestamibi-gated single-photon emission computed tomography for prediction of wall motion improvement in patients undergoing coronary artery bypass graft. Zafrir N, Arditi A, Ben-Gal T, Solodky A, Hassid Y, Sulkes J, Battler A. Clin Cardiol; 2003 Nov; 26(11):530-5. PubMed ID: 14640470 [Abstract] [Full Text] [Related]
5. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Levine MG, McGill CC, Ahlberg AW, White MP, Giri S, Shareef B, Waters D, Heller GV. Am J Cardiol; 1999 Jan 01; 83(1):1-5. PubMed ID: 10073775 [Abstract] [Full Text] [Related]
6. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. Chua T, Kiat H, Germano G, Maurer G, van Train K, Friedman J, Berman D. J Am Coll Cardiol; 1994 Apr 01; 23(5):1107-14. PubMed ID: 8144776 [Abstract] [Full Text] [Related]
9. Predictive value of 99Tcm-sestamibi gated SPET for long-term myocardial perfusion and functional recovery after an acute myocardial infarction. Solà M, Magriñà J, García A, Pavía J, Vidal-Sicart S, Huguet M, Paré C, Azqueta M, Setoain J. Nucl Med Commun; 1998 Sep 01; 19(9):823-30. PubMed ID: 10581588 [Abstract] [Full Text] [Related]
11. Comparative study of rest technetium-99m sestamibi SPET and low-dose dobutamine stress echocardiography for the early assessment of myocardial viability after acute myocardial infarction: importance of the severity of the infarct-related stenosis. Claeys MJ, Rademakers FE, Vrints CJ, Krug B, Bosmans JM, Conraads V, Bossaert LL, Snoeck JP, Blockx PP. Eur J Nucl Med; 1996 Jul 01; 23(7):748-55. PubMed ID: 8662112 [Abstract] [Full Text] [Related]
17. [Evaluation of coronary revascularization: comparison between perfusion with dipyridamole Tc99m sestaMIBI and amrinone-echocardiography as predictors of viability]. Massardo T, González P, Yovanovich J, Maiers E, Ayala F, Ramírez A, Berr JL, Zamorano J, Humeres P, Muñoz A. Rev Med Chil; 1994 Dec 01; 122(12):1353-61. PubMed ID: 7659908 [Abstract] [Full Text] [Related]
18. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, Koch KC, Uebis R, Messmer BJ, Buell U, Hanrath P. J Nucl Med; 1997 May 01; 38(5):742-8. PubMed ID: 9170439 [Abstract] [Full Text] [Related]